Petros pharmaceuticals expands online distribution for prescription stendra(r) (avanafil) through new agreement with lemonaid health

Collaboration with leading telemedicine provider to offer marketing and distribution of stendra for lemonaid health's ed patients (please see important safety information below) new york, ny / accesswire / april 23, 2024 / petros pharmaceuticals, inc. (nasdaq:ptpi), a company focused on expanding consumer access to medication through over-the- counter (otc) drug development programs, announces a new collaboration with lemonaid health, leading telemedicine provider and a subsidiary of 23andme, serving hundreds of thousands of patients with quality healthcare. as part of the collaboration, prescription stendra® (avanafil) in all strengths will be available through lemonaid health's telehealth platform.
PTPI Ratings Summary
PTPI Quant Ranking